eGenesis logo

eGenesis

ID: 5290132

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases

5

Funding Rounds

$457.2m

Money raised

Overview

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company eGenesis has raised a total of $191m in funding over 5 rounds.

Key Insights:

  • eGenesis September 2024 Series D Funding round: $191m
  • eGenesis Series B round November 2019: $100m
  • eGenesis, Inc. funding round, March 2017: $38.19m
  • eGenesis, Inc. funding round, August 2016: $3m
  • eGenesis, Inc. funding round, March 2021: $125m

Industries

eGenesis is active in the following industries: